Toragen Competitors and Similar CompaniesClear all
Toragen's competitors and similar companies include Xencor, Bio-Path Holdings, CyTuVax and Splash Pharmaceuticals.
 Xencor Xencor is a clinical-stage biopharmaceutical company which focuses on discovery and development of engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs. |  Bio-Path Holdings Bio-Path Holdings is a clinical and preclinical stage oncology focused antisense drug development company. |  CyTuVax CyTuVax is a company that develops therapeutic vaccines against cancer and protective vaccines against viral and bacterial pathogens. | |||
Founding Date | Founding Date 2016 | Founding Date 1997 | Founding Date 2007 | Founding Date 2012 | Founding Date 2001 |
Type | Type Private | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations San Diego, US HQ | Locations Pasadena, US HQ San Diego, US | Locations Bellaire, US HQ | Locations Maastricht, NL HQ | Locations San Diego, US HQ |
Employees | Employees 614% decrease | Employees 2604% increase | Employees 913% increase | Employees N/A | Employees 1 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.5 b | Valuation ($) 4 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Net income | Net income N/A | Net income ($92.1m) (FY, 2025) | Net income ($9.9m) (FY, 2024) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 5.4m (over 3 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 22.5m (over 17 years ago) |
Total funding raised | Total funding raised $ 5.4m | Total funding raised $ 108.4m | Total funding raised $ 2.3m | Total funding raised N/A | Total funding raised $ 23m |
For sources of this data, please see the company profile
View Company Profiles
Xencor
HQ
Pasadena, US
Employees
260↑ 4% increase
Xencor is a clinical-stage biopharmaceutical company which focuses on discovery and development of engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs.
View companyBio-Path Holdings
HQ
Bellaire, US
Employees
9↑ 13% increase
Bio-Path Holdings is a clinical and preclinical stage oncology focused antisense drug development company.
View companyCyTuVax
HQ
Maastricht, NL
CyTuVax is a company that develops therapeutic vaccines against cancer and protective vaccines against viral and bacterial pathogens.
View company
Splash Pharmaceuticals
HQ
San Diego, US
Employees
1
Splash Pharmaceuticals is a cancer therapy company.
View company